Company Offers Most Comprehensive, Cost-Effective Suite of Solutions to Detect and Screen for Methicillin Resistant Staphylococcus aureus (MRSA)
Asia
Europe, Middle East, Africa
North America
bioMérieux Presents 2011 Sonnenwirth Award for Leadership in Clinical Microbiology to Melvin Weinstein
23 May, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce Melvin Weinstein, M.D., as the 2011 recipient of the bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology.
bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition
20 May, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, has signed an agreement to acquire AES Laboratoire, a leading French group, specialized in industrial microbiological control, for 183 million euros. This will be bioMérieux’s ninth acquisition in five years and its third in the area of industrial applications.
FDA Clears First Test for Recent Infection with Toxoplasmosis Parasite
18 May, 2011
On May 18, the U.S. Food and Drug Administration cleared the first test to help determine whether a pregnant woman or a person with swollen lymph nodes testing positive for toxoplasmosis, developed the infection within the past four months.
First-Quarter 2011 Business Review
21 April, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2011. Net sales for the period reached €328 million, up a reported 6.8% from €307 million in first-quarter 2010. Growth amounted to 3.5% like-for-like (at constant exchange rates and scope of consolidation).
bioMérieux Achieves 100th PREVI® ISOLA Milestone, Installing its Automated Plate Streaker at Grady Health System
12 April, 2011
Innovative system designed by microbiologists for microbiologists helps a growing number of labs achieve substantial productivity gains.
bioMérieux Results 2010
08 March, 2011
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met today and approved the consolidated financial statements for the year ended December 31, 2010. The meeting was chaired by Jean-Luc Bélingard and attended by the Statutory Auditors. The financial statements have been audited and the Statutory Auditors will be issuing an unqualified opinion in the coming days.
Ipsen and bioMérieux Enter into a Broad Partnership in Personalized Medicine
25 February, 2011
The two companies leverage combined expertise in therapeutics and in diagnostics to improve patient care
Philips and bioMérieux Announce Milestone in the Development of Innovative Handheld Diagnostic Solutions for Rapid Point-of-Care Testing
27 January, 2011
Combination of Philips’ Magnotech technology and bioMérieux’s assay technology achieves the performance requirements of rapid diagnostic testing in point-of-care applications
bioMérieux - 2010 Business Review
19 January, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2010.